eMultipleSclerosis Review Extended to Further Close Practice Gaps in Multiple Sclerosis Care

eMultipleSclerosis Review Extended to Further Close Practice Gaps in Multiple Sclerosis Care
Contact: Matt Miller
Phone: 646-336-6495
Fax: 646-336-6497
Email: [email protected]

NEW YORK (2/13/2023) – DKBmed LLC, together with the John Hopkins School of Medicine and the Institute for Johns Hopkins Nursing, is releasing a fresh fifth installment and a special edition of its eMultipleSclerosis Review series. This online literature review series curates the latest medical literature and succinctly illustrates how clinicians can apply new findings and treatments into routine practice.

Renewal of the program comes after the success of Volume 4, which drew over 6,700 participants, 4,900 app downloads, and over 43,000 page views. After completing Volume 4, 95% of readers and podcast listeners agreed their medical practice knowledge improved. Multiple sclerosis (MS) is a highly heterogenous, demyelinating disorder estimated to affect approximately 2.1 million individuals worldwide. Through the fifth volume of the eMultipleSclerosis Review series, neurologists and other clinicians can gain greater insights on:

  • New and emerging disease-modifying treatments (DMTs)
  • Strategies to reduce infection risks when using DMTs
  • Ways to ensure equal access to care

Like its predecessors, this new volume of the eMultipleSclerosis Review series will consist of six journal briefs delivered bimonthly and six case-based podcasts/webcasts delivered on alternating months. Each brief, written by a clinician with expertise in that brief’s topic, reviews the most relevant literature pertinent to the specific topic whereas each podcast/webcast assesses patient cases and models ways in which clinicians can improve their practice using information provided in the preceding journal brief.

“Although therapeutics have advanced considerably in the last two decades, MS still lacks a cure and is a lifelong condition that can sometimes cause serious disability,” notes Dr. Melanie Ward, Assistant Professor at WVU Department of Neurology. “Resources, such as the eMultipleSclerosis review, are vital in closing practice gaps and providing more effective patient care In addition, eMultipleSclerosis Review Special Edition 2023 will specifically examine spasticity, one of the most bothersome symptoms of MS and the safety and efficacy of cannabis-based treatments.”

The program can be found at ems.dkbmed.com

eMultipleSclerosis Review is one component of the highly successful and popular eLiterature Review series published by DKBmed.

Credit Designation Statements

Physicians
eNewsletter: The Johns Hopkins University School of Medicine designates this enduring material – Internet activity for a maximum 6.0 AMA PRA Category 1 CreditsTM (1 AMA PRA Category 1 CreditTM per monthly review). Physicians should only claim credit commensurate to the extent of their participation in the activity.
Podcast/Webcast: The Johns Hopkins University School of Medicine designates this enduring material – Internet activity for a maximum of 3.0 AMA PRA Category 1 CreditsTM.

Nurses
eNewsletter: This 1 contact hour Educational Activity is provided by the Institute for Johns Hopkins Nursing. Each Newsletter carries a maximum of 1 contact hour, or a total of 6.0 contact hours for the 6 newsletters in this program.
Podcast: These paired, 0.5 contact hour Educational Activities are provided by the Institute for Johns Hopkins Nursing. Each podcast carries a maximum of 0.5 contact hour, or a total of 3.0 contact hours for the 6 podcasts in the program.

Disclosure of Support

Volume 5 of eMultipleSclerosis Review is supported by educational grants from Biogen, Inc. and Novartis Pharmaceuticals Corporation. Special Edition of eMultipleSclerosis Review is supported by an educational grant from Jazz Pharmaceuticals, Inc.

About DKBmed

DKBmed is an integrated continuing medical education company operated by an experienced team of medical education experts. DKBmed provides health care professionals with effective medical education that closes identified knowledge and practice gaps to improve patient health.

Working with accredited providers and other partners, DKBmed develops innovative educational programs and quality improvement (QI) initiatives, bringing new learning methodologies to the CME landscape. DKBmed has become a leader in QI in the independent medical education space with QI projects in Pain Management, HIV, Depression, Influenza, and Diabetic Eye Disease. DKBmed was also an early adopter of case scenarios with real patients and live actors, TED/DKBmed Talks, 3D animation, webcasts, podcasts, and smart phone applications for clinicians and patients. These forward-thinking approaches enable health care professionals to learn and access educational programs in a manner that is most convenient and appropriate for them.

DKBmed’s programs are accessible through the company’s website (www.dkbmed.com). They reach more than 150,000 health care professionals in primary care and in a variety of specialties and disease states including: HIV, COVID-19, cystic fibrosis, diabetes, influenza, dermatology, retinal disease, rheumatoid arthritis, COPD, asthma, multiple sclerosis, pain management, depression and viral hepatitis (HBV, HCV) and oncology.